Mounjaro Weight Loss - Park Avenue Endocrinology

Mounjaro: A New Approach to Diabetes

What is Mounjaro?

Mounjaro (tirzepatide) is a new injectable medication designed for the treatment of type 2 diabetes, offering groundbreaking results in blood sugar management. It is the first medication that targets two key hormone pathways—GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide)—which play crucial roles in controlling blood sugar levels and appetite. By activating both of these hormone receptors, Mounjaro offers a dual-action approach that has been shown to significantly improve glycemic control.

For individuals with type 2 diabetes, Mounjaro helps reduce blood sugar. At Park Avenue Endocrinology, we offer Mounjaro as part of a comprehensive diabetes management plan, helping patients achieve better control of their health.

How Mounjaro Works

Mounjaro is unique because it targets two incretin hormones—GLP-1 and GIP. These hormones are naturally produced in the gut and released in response to food intake, helping regulate insulin production, glucose absorption, and appetite. Mounjaro’s dual-action mechanism has several benefits that make it a powerful option for managing type 2 diabetes.

By activating GLP-1 receptors, Mounjaro stimulates the pancreas to produce more insulin when blood sugar is elevated. It also slows down the emptying of the stomach, leading to a prolonged feeling of fullness after eating. This helps stabilize blood sugar.

At the same time, Mounjaro activates GIP receptors, which further enhances the body’s ability to manage glucose. Together, these hormone pathways work to regulate both blood sugar and appetite more effectively than medications that target GLP-1 alone.

Mounjaro Dosage: How It’s Administered

The Mounjaro dosage is designed to be administered once a week via a subcutaneous injection, typically in the abdomen, thigh, or upper arm. As with many injectable medications, Mounjaro starts at a lower dose to allow the body to adjust before gradually increasing to a higher maintenance dose. This stepwise approach helps reduce the likelihood of side effects, particularly gastrointestinal discomfort.

The starting dose for Mounjaro is generally 2.5 mg once a week for the first month. After four weeks, the dose may be increased to 5 mg once a week. Depending on how the patient responds to the medication, the dose can be further increased, with the maximum dose typically being 15 mg once a week.

It’s important to follow the dosing schedule recommended by your healthcare provider to ensure that the medication is effective and to minimize any potential side effects. At Park Avenue Endocrinology, we work closely with our patients to ensure they are using Mounjaro correctly. We provide education on how to administer the injections and monitor progress to adjust the dosage if necessary.

What People Say About Us!

"As I have said many times before, Dr. Eytan is brilliant. She’s smart, knowledgeable. She has helped me lose weight and more importantly, my health markers are all now normal or vastly improved. She warm & caring and discusses all options with you for treatment. I highly recommend her."

- LISA C.

Click here to read more reviews.

Mounjaro and Type 2 Diabetes: Managing Blood Sugar

Mounjaro has proven to be highly effective in managing blood sugar levels in individuals with type 2 diabetes. By targeting both GLP-1 and GIP receptors, Mounjaro helps the body produce insulin more efficiently while reducing the amount of glucose released by the liver. This results in improved glycemic control and lower A1C levels, which are key indicators of long-term blood sugar management.

For individuals with type 2 diabetes who have struggled to achieve adequate blood sugar control with other medications, Mounjaro offers a new and more comprehensive approach. The dual hormone action means that blood sugar levels are managed more effectively, and the risk of dangerous blood sugar spikes after meals is reduced.

In clinical trials, patients using Mounjaro have seen substantial reductions in their A1C levels, with many achieving A1C goals that were previously difficult to reach with other treatments. This makes Mounjaro a valuable option for individuals seeking better long-term control of their diabetes.

Mounjaro Side Effects: What to Watch For

As with any medication, Mounjaro may cause side effects, though many are mild and improve as the body adjusts to the treatment. The most common side effects are related to the gastrointestinal system, particularly during the early stages of treatment when the dosage is being gradually increased.

The most frequently reported side effects include nausea, vomiting, diarrhea, and constipation. These side effects tend to be temporary and usually subside after the first few weeks of treatment. To minimize these effects, patients are started on a low dose of Mounjaro, and the dose is slowly increased over time.

Some individuals may experience more serious side effects, such as pancreatitis, which is inflammation of the pancreas. Symptoms of pancreatitis include severe stomach pain that radiates to the back, along with nausea and vomiting. If you experience these symptoms, it’s important to contact your healthcare provider immediately.

Mounjaro may also cause a slight increase in the risk of thyroid tumors, though this has only been observed in animal studies and not in human trials. Individuals with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) should not use Mounjaro.

At Park Avenue Endocrinology, we monitor our patients closely for any side effects and provide guidance on how to manage any discomfort. Most side effects can be effectively managed, and the benefits of Mounjaro for blood sugar control outweigh the risks for most individuals.

Is Mounjaro Right for You?

Mounjaro Side Effects, Mounjaro and Type 2 Diabetes, Mounjaro Dosage

Mounjaro is a promising treatment option for individuals with type 2 diabetes who are seeking better glycemic control.

However, not everyone is a candidate for Mounjaro. Individuals with a history of pancreatitis or a family history of thyroid cancer should avoid the medication. Additionally, Mounjaro should only be used under the guidance of a healthcare provider who can assess your overall health and determine if it’s the right option for your diabetes goals.

At Park Avenue Endocrinology, we offer comprehensive consultations to help you determine whether Mounjaro is a suitable option for you. Our team will review your medical history, discuss your health goals, and provide you with the information you need to make an informed decision.